
From historic USPSTF draft screening recommendations to the need for novel treatments for bipolar depression, here are highlights from the week in Psychiatric Times.

From historic USPSTF draft screening recommendations to the need for novel treatments for bipolar depression, here are highlights from the week in Psychiatric Times.

In this CME article, learn more about the rationale for considering novel treatments for patients with bipolar depression.

The FDA has accepted the NDA for aripiprazole 2-month, ready-to-use, long-acting injectable.

Researchers performed a systematic review and meta-analysis of the prevalence of bipolar disorder and associated mood episodes in perinatal women.

In this CME article, examine how current DSM nosology defines the proper method of assessing a mixed-episode patient and which diagnostic labels to give them based on their presenting symptomatology.

This diet was associated with significant reductions in variability of symptoms in patients with bipolar disorder.

What is a mood disorder and what are the early warning signs? What treatments are available?

Cardiometabolic risk factors for suicide? Researchers investigated associations between obesity/metabolic syndrome and suicidality in patients with bipolar disorder.

A retired US Army major general and bipolar survivor and thriver shares his story of hope and healing.

Do your patients have abnormal thyroid indices? Researchers performed a comparison of thyroid function based on mood state in drug-naïve patients with bipolar disorder.

The eyes are a window to the brain. Researchers performed a nationwide cohort study of the risk of retinal disease in patients with bipolar disorder.

Researchers performed a meta-analysis of the prevalence of type 2 diabetes, impaired fasting, glucose, and general and abdominal obesity in bipolar disorder.

Gus Alva, MD, DFAPA, discusses key takeaways for the management of bipolar disorder.

Dr. Gus Alva shares his initial impressions on this case and treatment approaches to bipolar 1 disorder.

Gus Alva, MD, DFAPA, presents the case of a 23-year-old female diagnosed with bipolar 1 disorder.

Adjunctive metformin in bipolar disorder. Researchers performed a randomized clinical trial of treating insulin resistance to improve clinical outcomes in treatment-resistant bipolar depression.

What are the differences in epidemiological and clinical characteristics of bipolar disorder between the sexes?

Up to 20% of patients with bipolar disorder have 4 or more medications, so it is important to be aware of these common drug-drug interactions.

Dr Moukaddam discusses key takeaways for the management of bipolar disorder.

Nidal Moukaddam, MD, PhD, provides insight on the evolving treatment landscape for bipolar disorder and optimizing therapies for disease management.

Dr Moukaddam shares factors to consider when approaching the treatment of bipolar disorder.

Nidal Moukaddam, MD, PhD, presents the case of a 30-year-old male diagnosed with bipolar 1 disorder and shares her initial impressions on diagnosis.

Researchers performed a randomized controlled trial of a high n-3, low n-6 polyunsaturated fatty acid diet in bipolar disorder.

Lithium for bone health? Researchers performed a retrospective cohort study to evaluate the effects of lithium on risk of osteoporosis in bipolar disorder.

Evidence review focuses on bipolar disorder, psychosis, and major depression.